IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Argos Therapeutics Inc (ARGSQ)

CUSIP: 040221202 | UV | 19 institutional holders

Quarters

Q4 2025Q3 2022Q2 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Motiv8 Investments LLC40
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Motiv8 Investments LLC
40$00.0%GrowthMediumPort St. Lucie, FL2026-02-13